Showing results (371-380 of 403) with videos related to

Sort By:
Pageof 41
The Journal of Pharmacology and Experimental Therapeutics|April 18, 2024
Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in MiceEdna J Santos, Hamid I Akbarali, Eric W Bow, et al.
RSC Medicinal Chemistry|January 22, 2021
G-Protein biased opioid agonists: 3-hydroxy-<i>N</i>-phenethyl-5-phenylmorphans with three-carbon chain substituents at C9Eugene S Gutman, Eric Bow, Fuying Li, et al.
Bioconjugate Chemistry|December 19, 2023
Enhancing Protective Antibodies against Opioids through Antigen Display on Virus-like ParticlesFatemeh Shafieichaharberoud, Shuyao Lang, Connor Whalen, et al.
Molecules (Basel, Switzerland)|June 28, 2023
Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphansJoshua A Lutz, Agnieszka Sulima, Eugene S Gutman, et al.
ACS Chemical Neuroscience|July 9, 2019
Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens ShellXiaohui Wang, Alexis L Northcutt, Thomas A Cochran, et al.
Bioorganic & Medicinal Chemistry|December 12, 2001
CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonistsLing-Wei Hsin, Xinrong Tian, Elizabeth L Webster, et al.
Molecules (Basel, Switzerland)|October 14, 2022
A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and AntagonistsDana R Chambers, Agnieszka Sulima, Dan Luo, et al.
Frontiers in Neuroscience|January 7, 2016
A Transgenic Rat for Investigating the Anatomy and Function of Corticotrophin Releasing Factor CircuitsMatthew B Pomrenze, E Zayra Millan, F Woodward Hopf, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2019
Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signalingXiaozheng Zhang, Yinghua Peng, Peter M Grace, et al.
Organic & Biomolecular Chemistry|July 5, 2014
Synthesis and immunological effects of heroin vaccinesFuying Li, Kejun Cheng, Joshua F G Antoline, et al.
Pageof 41